Literature DB >> 23809190

NMO sera down-regulate AQP4 in human astrocyte and induce cytotoxicity independent of complement.

Hiroyo Haruki1, Yasuteru Sano, Fumitaka Shimizu, Masatoshi Omoto, Ayako Tasaki, Mariko Oishi, Michiaki Koga, Kazuyuki Saito, Toshiyuki Takahashi, Tsutomu Nakada, Takashi Kanda.   

Abstract

Autoantibodies against astrocyte water channel aquaporin-4 (AQP4) are highly specific for neuromyelitis optica (NMO). However, the molecular mechanism of NMO still remains unclear. The purpose of this study was to identify the possible humoral mechanisms responsible for the occurrence of astrocytic damage. Human primary astrocytes (AST) were immortalized by retroviral vectors harboring temperature-sensitive SV40 T antigen gene and AQP4 cDNA (M23), designated as hAST-AQP4. The effects of NMO sera on the content and localization of AQP4, including cytotoxicity and astrocytic morphology, were evaluated. In addition, this study examined whether the amount and localization of AQP4 protein in astrocytes were influenced by direct contact with the immortalized human brain microvascular endothelial cell line, TY09. NMO sera alone induced cytotoxicity and addition of complement had a more harmful effect on hAST-AQP4. NMO sera also decreased AQP4 mRNA and protein. NMO sera alone up-regulated TNFα and IL-6 in astrocytes and co-incubation with anti-TNFα and anti-IL-6 neutralizing antibodies blocked both the cytotoxicity and reduction of AQP4 in astrocytes. In the experiment using the in vitro BBB models, AQP4 protein mainly localized at the astrocytic membrane after co-culture with TY09, in contact with TY09. The future elucidation of factors that up-regulate AQP4 in astrocytes presumably released by blood brain barrier forming endothelial cells and that block the production of inflammatory cytokines may therefore lead to the development of a novel therapeutic strategy.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aquaporin 4; Astrocyte; Blood–brain-barrier; Co-culture; Cytokine; Endothelial cell; Neuromyelitis optica

Mesh:

Substances:

Year:  2013        PMID: 23809190     DOI: 10.1016/j.jns.2013.05.035

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  18 in total

1.  An in vitro blood-brain barrier model combining shear stress and endothelial cell/astrocyte co-culture.

Authors:  Yukio Takeshita; Birgit Obermeier; Anne Cotleur; Yasuteru Sano; Takashi Kanda; Richard M Ransohoff
Journal:  J Neurosci Methods       Date:  2014-05-22       Impact factor: 2.390

2.  Autoantibody-induced internalization of CNS AQP4 water channel and EAAT2 glutamate transporter requires astrocytic Fc receptor.

Authors:  Shannon R Hinson; Ian C Clift; Ningling Luo; Thomas J Kryzer; Vanda A Lennon
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-01       Impact factor: 11.205

3.  An In Vitro Model of the Blood-Brain Barrier to Study Alzheimer's Disease: The Role of β-Amyloid and Its Influence on PBMC Infiltration.

Authors:  Simona Federica Spampinato; Yukio Takeshita; Birgit Obermeier
Journal:  Methods Mol Biol       Date:  2022

4.  Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica.

Authors:  Fumitaka Shimizu; Kristin L Schaller; Gregory P Owens; Anne C Cotleur; Debra Kellner; Yukio Takeshita; Birgit Obermeier; Thomas J Kryzer; Yasuteru Sano; Takashi Kanda; Vanda A Lennon; Richard M Ransohoff; Jeffrey L Bennett
Journal:  Sci Transl Med       Date:  2017-07-05       Impact factor: 17.956

5.  Affinity-matured 'aquaporumab' anti-aquaporin-4 antibody for therapy of seropositive neuromyelitis optica spectrum disorders.

Authors:  Tianjiao Duan; Lukmanee Tradtrantip; Puay-Wah Phuan; Jeffrey L Bennett; Alan S Verkman
Journal:  Neuropharmacology       Date:  2019-10-22       Impact factor: 5.250

6.  Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?

Authors:  Simona F Spampinato; Birgit Obermeier; Anne Cotleur; Anna Love; Yukio Takeshita; Yasuteru Sano; Takashi Kanda; Richard M Ransohoff
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

7.  Markedly increased IP-10 production by blood-brain barrier in neuromyelitis optica.

Authors:  Fumitaka Shimizu; Hideaki Nishihara; Yasuteru Sano; Yukio Takeshita; Shiori Takahashi; Toshihiko Maeda; Toshiyuki Takahashi; Masaaki Abe; Michiaki Koga; Takashi Kanda
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

8.  Effects of neuromyelitis optica-IgG at the blood-brain barrier in vitro.

Authors:  Yukio Takeshita; Birgit Obermeier; Anne C Cotleur; Simona F Spampinato; Fumitaka Shimizu; Erin Yamamoto; Yasuteru Sano; Thomas J Kryzer; Vanda A Lennon; Takashi Kanda; Richard M Ransohoff
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-12-19

Review 9.  Homeostasis of the Intraparenchymal-Blood Glutamate Concentration Gradient: Maintenance, Imbalance, and Regulation.

Authors:  Wei Bai; Yuan-Guo Zhou
Journal:  Front Mol Neurosci       Date:  2017-12-05       Impact factor: 5.639

10.  Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.

Authors:  Maarten J Titulaer; Romana Höftberger; Takahiro Iizuka; Frank Leypoldt; Lindsey McCracken; Tania Cellucci; Leslie A Benson; Huidy Shu; Takashi Irioka; Makito Hirano; Gagandeep Singh; Alvaro Cobo Calvo; Kenichi Kaida; Pamela S Morales; Paul W Wirtz; Tomotaka Yamamoto; Markus Reindl; Myrna R Rosenfeld; Francesc Graus; Albert Saiz; Josep Dalmau
Journal:  Ann Neurol       Date:  2014-03       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.